Indivior

United States
Forest Hill, Texas, United States

Company profile

Indivior company profile

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.

Business identity

Contact email
[email protected]
Phone number
+1 804 379 1090
Operating status
Active
Company type
For Profit
Employee range
1,001-5,000 employees
Revenue range
$100M-$1B
Founded
2014-12-01, Month

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
2
Last funding
Post IPO Debt / $400M / 2024-11-05
Last equity funding
Post IPO Equity
Investors
2
Lead investors
2
Articles
410
Exited on
2014-12-23

Founders and investors

Lead investors

Oaktree Capital ManagementPiper Sandler

Investors

Oaktree Capital ManagementPiper Sandler